Cone-Rod Dystrophies clinical trials

The registry lists 39 studies for Cone-Rod Dystrophies across more than 10 countries. 14 are recruiting or about to start. 10 of them are mainly about Cone-Rod Dystrophies (how this is decided). Per ClinicalTrials.gov, last updated 2026-11-10.

Get an email when these change. Save the Cone-Rod Dystrophies studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Watch these studies

See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your saved searches, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your saved searches. Stop any time.

Status

Recruiting: 13
Completed: 10
Status unknown: 7
Active, not recruiting: 5
Terminated: 3
Not yet recruiting: 1

Phase

Phase 2: 9
Phase 1: 9
Phase 3: 1

Where

United States: 19
France: 10
Germany: 5
United Kingdom: 3
China: 3
Austria: 3

Who runs them

SparingVision (5) · National Eye Institute (NEI) (2) · Science Corporation (2) · MD Stem Cells (2) · Ascidian Therapeutics, Inc (2) · University Hospital, Lille (1) · Hospital Universitario Dr. Jose E. Gonzalez (1) · GenSight Biologics (1)

What is being tested here

Drugs under test in Cone-Rod Dystrophies studies, those with the most open studies first. Medicines only given beside them are not counted. How drugs are counted

Drug	Open	Phase 3	All
Cholesterol	1	0	1
Recombinant human nerve growth factor	0	0	1
Botulinum toxin type A	0	1	1
Interferon gamma-1b	0	0	1

Coming up

0phase 3 studies under way

7studies finish main data collection within a year

Studies recruiting or running, from their records. “Main data collection” ends at the primary completion date, the sponsor’s own estimate, which often moves.

All 7

Dec 2026EyeConic: Qualification for Cone-Optogenetics · Institute of Molecular and Clinical Ophthalmology Basel
Feb 2027Promising ROd-cone DYstrophy Gene therapY · SparingVision
Mar 2027Observational Study to Investigate the Short-term Effects of Transcorneal Electrical Stimulation on Visual Performance · Okuvision GmbH
Jul 2027Stem Cell Ophthalmology Treatment Study II · MD Stem Cells
Aug 2027Brain Stimulation Effects on Orientation and Mobility Skills in Adults With Vision Impairment · University of Waterloo
Aug 2027Prescreening Study to Identify Potential Stargardt Participants for ACDN-01 Clinical Trials (STARPATH) · Ascidian Therapeutics, Inc
Oct 2027Dose-escalation Study to Evaluate the Safety and Tolerability of GS030 in Subjects With Retinitis Pigmentosa · GenSight Biologics

Who these studies take

Of the 13 Cone-Rod Dystrophies studies recruiting now, 10 (77%) set no upper age limit and 2 (15%) stop at 75 or younger. 5 (38%) take children under 18. 0 (0%) are for women only and 0 (0%) for men only; 3 (23%) take healthy volunteers.

Recruiting studies that take each age, of 13
Age	Women	Men
10	5 (38%)	5 (38%)
18	12 (92%)	12 (92%)
30	13 (100%)	13 (100%)
40	13 (100%)	13 (100%)
50	13 (100%)	13 (100%)
65	13 (100%)	13 (100%)
75	11 (85%)	11 (85%)
85	11 (85%)	11 (85%)

Across all 39 studies, recruiting or not: 33% stop at 75 or younger and 26% at 65; 33% take children; 0% are for women only and 3% for men only; 18% take healthy volunteers. From each study’s registry entry; the criteria on its page decide.

Studies

Recruiting first, then most recently updated. Showing 39 of 39. search them.